Vaxcyte is a clinical-stage vaccine company. Co. is developing conjugate and protein vaccines to treat bacterial infectious diseases. Co.'s primary vaccine candidate, VAX-24, is a 24-valent investigational pneumococcal conjugate vaccine (PCV) for the treatment of invasive pneumococcal disease and pneumonia. Co.'s second PCV candidate, VAX-XP, is designed to expand the breadth of coverage to greater than 30 strains without compromising immunogenicity due to carrier suppression. In addition, Co.'s pipeline includes VAX-A1, a conjugate vaccine candidate designed to treat Group A Strep and VAX-PG, a protein vaccine candidate targeting the keystone pathogen responsible for periodontitis. We show 1 historical shares outstanding datapoints in our PCVX shares outstanding history coverage, used to compute PCVX market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing PCVX market cap history over the course of time is important for investors
interested in comparing PCVX's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of PCVX versus a peer is one thing; comparing
PCVX market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like PCVX can fluctuate over the course of history.
With this page we aim to empower investors researching PCVX by allowing them to research the PCVX market cap history. |
Free PCVX Email Alerts:
Video: The Importance of Market Cap
